FDA approval

Regeneron’s Veopoz scores FDA approval for rare immune disease

Regeneron Pharmaceuticals has received US Food and Drug Administration (FDA) approvals for two of its drugs, namely Veopoz (pozelimab-bbfg) and…

Pfizer’s Elrexfio tries to challenge Janssen in RRMM with FDA approval

Pfizer’s Elrexfio (elranatamab-bcmm) has received accelerated approval from the US Food and Drug Administration (FDA) to treat adults with relapsed…